drugset / Trial / NCT02404922
Multiple Ascending Dose Study in Healthy Volunteers
RandomizedParallel-groupTriple-blindBasic science
Summary
This study will assess in healthy male and female subjects the safety, tolerability and pharmacokinetics (PK) profiles of Immediate Release CTP-730 at steady state following 7 days of dosing. Three doses of Immediate Release (IR) CTP-730 capsules will be studied.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-730 | Unknown | — | Oral |
Indications
No indication recorded.